Strong H1 and Q2 results with robust sales and EBITDA growth, margin improvement, and solid cash generation. Outlook for 2026 remains confident, supported by cost programs, innovation, and disciplined capital allocation, despite FX headwinds and some restocking uncertainty.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.